Market Research Logo

Germany Pharmaceuticals and Healthcare Report Q2 2016

Germany Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Germany's macroeconomic environment will continue to be favourable for drugmakers andhealthcare operators through 2016. Buoyant private consumption and higher public expenditure, broughtabout by migrant/refugee accommodation and social security payments, will appeal to multinationaldrugmakers. Furthermore, in order to mitigate Germany's dire demographics and growing social securityspending brought about by an ageing population, there has been a broader trend in the introduction ofnovel and costly therapies in Germany, leading us to revise upwards our pharmaceuticals market forecastfor 2016.

Headline Expenditure Projections

Pharmaceuticals: EUR46.50bn (USD51.15bn) in 2015 to EUR47.10bn (USD50.40bn) in 2016; 1.3% inlocal currency terms and -1.5% in US dollar terms. Forecast revised upwards from last quarter.

Healthcare: EUR326.08bn (USD358.69bn) in 2015 to EUR335.11bn (USD358.56bn) in 2016; +2.8% inlocal currency terms and -0.04% in US dollar terms. Forecast broadly in line with last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Germany 2014
2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Germany 2012
2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012
2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012
2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012
2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Germany 2012
2020)
Table: Retail Pharmaceutical Expenditure, 2003
2010 (EURbn)
Table: Retail Pharmaceutical Expenditure, 2003
2010 (Packages, ms)
Table: Retail Pharmaceutical Expenditure, 2003
2010 (Average Price per Pack, EUR)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Germany 2012
2020)
Generic Medicine Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Germany 2012
2020)
OTC Medicine Market Forecast
Table: Over
TheCounter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Germany 20122020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Germany 2014
2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Germany 2014
2020)
Pharmaceuticals Risk/Reward Index
Western Europe Risk/Reward Index
Germany Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Regime
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Germany 2010
2015)
Table: Healthcare Personnel (Germany 2010
2015)
Table: Healthcare Activity (Germany 2010
2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
ResearchBased Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Bayer Health Care
Boehringer Ingelheim
GlaxoSmithKline (GSK)
Merck KGaA
Pfizer
STADA Arzneimittel
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Germany 1990
2025)
Table: Key Population Ratios (Germany 1990
2025)
Table: Urban/Rural Population & Life Expectancy (Germany 1990
2025)
Table: Population By Age Group (Germany 1990
2025)
Table: Population By Age Group % (Germany 1990
2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report